ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

Clinical trial NCT06998407 · RECRUITING

Trial details

NCT number: NCT06998407
Sponsor: Avenzo Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HR+/HER2- Breast Cancer HR+, HER2-, Advanced Breast Cancer

Start date: 2025-08-20
Primary completion: 2028-08-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.